Aerospan flunisolide HFA regulatory update

FDA approved an sNDA from Acton for Aerospan flunisolide HFA as maintenance treatment of asthma in patients >=6 years of age. Acton plans to launch the hydrofluoroalkane (HFA)-propelled inhaled formulation of flunisolide in the U.S. early next year. ...